Intersectional transgenic targeting of discrete neuronal and glial subtypes
离散神经元和神经胶质亚型的交叉转基因靶向
基本信息
- 批准号:10259997
- 负责人:
- 金额:$ 192.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-27 至 2024-08-26
- 项目状态:已结题
- 来源:
- 关键词:AblationAntibiotic ResistanceBiological ModelsBrainBrain regionCalciumCell NucleusCell physiologyCellsDNA Binding DomainEnsureFibrinogenFishesFundingGene Transfer TechniquesGenesGoalsKnock-inLabelLettersMediatingMethodsModelingMonitorNatureNervous system structureNeurogliaNeuronsNeurotransmittersNitroreductasesOutcomePeptidesProdrugsReporterRepressor ProteinsResourcesSeriesSpecificityStructureSystemTestingTransactivationTranscription RepressorTransgenesTransgenic OrganismsVertebratesVisualizationZebrafishbasecell typecellular targetingcombinatorialdesignflyimprovedinterestnoveloptogeneticsresistance genetooltranscriptomicstransgene expressionvectorvoltage
项目摘要
PROJECT SUMMARY
Tools for exclusively targeting neuronal and glial subtypes are needed to advance our understanding of the brain.
“Intersectional” systems improve targeting by restricting “reporter/effector” transgenes to a subdomain defined
by the expression overlap between two activating factors. “Split-driver” systems have enhanced targeting
precision in flies and are operable in fish, but have yet to be systematically deployed in vertebrate systems. Our
goal is to improve transgene expression precision in the vertebrate nervous system by creating a series of
intersectional vectors designed to enable exclusive targeting of discrete neuronal and glial cell subtypes.
Binary systems, such as Gal4/UAS, separate transgene expression into “drivers” and “reporter/effectors”. The
combinatorial nature ensures versatility; however, most driver lines fail to target specific cell types. In turn, this
can compromise the integrity of reporter/effector-based manipulations. To enhance expression specificity,
drivers have been split into two “hemidriver” components: a DNA-binding domain (DBD) and transactivation
domain (AD). Hemidrivers can only be assembled where DBD and AD expression overlaps, thus restricting
driver-dependent reporter/effectors to the “intersect”. DBD-AD and reporter/effector activity can be further
refined by expressing repressor proteins in non-targeted domains. Moreover, efficient knock-in methods and
single-cell transcriptomics now afford an unprecedented level of transgene expression fidelity and targeting
precision. We propose to leverage these advances to create a series of DBD hemidriver, AD hemidriver, and
repressor toolsets for targeting discrete neuronal and glial subtypes. To further enhance targeting precision,
repressor resources will developed to inhibit effector activity in non-targeted cells. Given its utility in dissecting
cell function, we propose to identify genetic repressors of the nitroreductase (NTR) system of inducible targeted
cell ablation. While the utility of these resources will be validated in the zebrafish, universal vectors will be created
to facilitate adaptation to any other vertebrate model amenable to transgenesis. Three aims are proposed:
Aim 1: Create and validate tools for labeling and functionally dissecting discrete neuronal cell subtypes.
Aim 2: Create and validate tools for labeling and functionally dissecting discrete glial cell subtypes.
Aim 3: Create and validate tools for repressing effector activity non-targeted brain regions/cells.
Funding will allow us to create toolsets facilitating transgenic targeting at unparalleled levels of cellular and circuit
precision in the brain. We anticipate creating ~25 DBD, ~50 AD, and ~25 repressor vectors/lines, allowing
targeting of thousands of unique neuronal and glial subtypes. In combination with existing reporter/effectors
expressing optogenetic, cell ablation, transsynaptic and other tools for monitoring and manipulating cells and
circuits, the proposed resources will enable interrogations of elemental components of the nervous system,
substantially expanding our structural and functional understanding of the brain.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JEFFREY MUMM其他文献
JEFFREY MUMM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JEFFREY MUMM', 18)}}的其他基金
Innate immune system regulation of retinal regeneration
先天免疫系统对视网膜再生的调节
- 批准号:
10444471 - 财政年份:2022
- 资助金额:
$ 192.13万 - 项目类别:
Innate immune system regulation of retinal regeneration
先天免疫系统对视网膜再生的调节
- 批准号:
10707048 - 财政年份:2022
- 资助金额:
$ 192.13万 - 项目类别:
TERM: a novel mutagenesis paradigm enabling streamlined saturation forward genetics in vertebrate models
术语:一种新的诱变范例,可在脊椎动物模型中简化饱和正向遗传学
- 批准号:
10477464 - 财政年份:2021
- 资助金额:
$ 192.13万 - 项目类别:
TERM: a novel mutagenesis paradigm enabling streamlined saturation forward genetics in vertebrate models
术语:一种新的诱变范例,可在脊椎动物模型中简化饱和正向遗传学
- 批准号:
10288603 - 财政年份:2021
- 资助金额:
$ 192.13万 - 项目类别:
Improved Animal Models for Cell-Specific Regenerative Medicine Paradigms
细胞特异性再生医学范式的改进动物模型
- 批准号:
9104636 - 财政年份:2016
- 资助金额:
$ 192.13万 - 项目类别:
Improved Animal Models for Cell-Specific Regenerative Medicine Paradigms
细胞特异性再生医学范式的改进动物模型
- 批准号:
9206193 - 财政年份:2016
- 资助金额:
$ 192.13万 - 项目类别:
Genetic and Chemical Screens for Factors Regulating Retinal Regeneration
遗传和化学筛选调节视网膜再生的因素
- 批准号:
8771054 - 财政年份:2014
- 资助金额:
$ 192.13万 - 项目类别:
Genetic and Chemical Screens for Factors Regulating Retinal Regeneration
遗传和化学筛选调节视网膜再生的因素
- 批准号:
8719118 - 财政年份:2014
- 资助金额:
$ 192.13万 - 项目类别:
Genetic and Chemical Screens for Factors Regulating Retinal Regeneration
遗传和化学筛选调节视网膜再生的因素
- 批准号:
8854178 - 财政年份:2014
- 资助金额:
$ 192.13万 - 项目类别:
Genetic and Chemical Screens for Factors Regulating Retinal Regeneration
遗传和化学筛选调节视网膜再生的因素
- 批准号:
9127241 - 财政年份:2014
- 资助金额:
$ 192.13万 - 项目类别:
相似海外基金
Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
- 批准号:
EP/Y031067/1 - 财政年份:2024
- 资助金额:
$ 192.13万 - 项目类别:
Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307222 - 财政年份:2024
- 资助金额:
$ 192.13万 - 项目类别:
Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
- 批准号:
502587 - 财政年份:2024
- 资助金额:
$ 192.13万 - 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307223 - 财政年份:2024
- 资助金额:
$ 192.13万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 192.13万 - 项目类别:
Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
- 批准号:
MR/X009580/1 - 财政年份:2024
- 资助金额:
$ 192.13万 - 项目类别:
Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
- 批准号:
2340818 - 财政年份:2024
- 资助金额:
$ 192.13万 - 项目类别:
Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
- 批准号:
480022 - 财政年份:2023
- 资助金额:
$ 192.13万 - 项目类别:
Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
- 批准号:
BB/X010473/1 - 财政年份:2023
- 资助金额:
$ 192.13万 - 项目类别:
Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
- 批准号:
10670613 - 财政年份:2023
- 资助金额:
$ 192.13万 - 项目类别: